Please login to the form below

Not currently logged in
Email:
Password:

Teva Generics Europe appoints president and CEO

Promotes former UK general manager Richard Daniell

Teva Richard DaniellTeva has appointed Richard Daniell as president and chief executive officer of Teva Generics Europe, following Dipankar Bhattacharjee's promotion to a global role.

Daniell has over 25 years of experience working at Teva and served as the company's chief integration officer, leading the integration programme to bring Actavis and Teva together.

Prior to this, he was chief operating officer, growth markets region and served as general manager of Teva UK from 2011 to 2015.

Bhattacharjee, president and chief executive of global generic medicines said: “Richard has shown visionary leadership, has built high-performing teams across the company and has an impressive record in driving commercial success.”

21st December 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles

With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize...

Latest intelligence

How will capitated budgets affect NHS spending?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess the implications of a single budget covering all the physical, mental and social care needs of patients in an STP...
Dissecting adherence to personalise patient support
Across the healthcare and pharmaceutical industries, the initiatives to better understand the patient journey and lower healthcare costs have been growing in magnitude. One solution that has repeatedly been raised...
A safe place to talk about Crohn’s
Published in eyeforpharma April 2017 by Mariel Metcalfe...

Infographics